WMIC 2018 MILabs Industry Session

Learn how the next generation of multimodality imaging systems enables advanced omni-tomographic imaging applications. Prof. Kah Whye Peng,  from the Mayo Clinic, will give the Keynote Lecture on multimodality non-invasive reporter gene imaging and oncolytic virology research. Dr. Felix Gremse, from the RWTH Aachen University Clinic in Germany, will share the latest advances in hybrid optical and near-infrared tomographic imaging. Also,  Prof. Frederik BeekmanCEO of MILabs, will present how broadband photon tomography takes the versatility of multi-modality preclinical imaging beyond the limits of current PET, SPECT, CT, and Optical Imaging.  
When: Saturday, September 15th from 8:00 – 9:30 am
Washington State Convention Center, Level 6, Room 612
Refreshments and light breakfast will be served. Register here.


MILabs Broadband Photon Tomography nominated for Innovation of the Year

MILabs is pleased to have been selected as a semi-finalist for the prestigious WMIC 2018 Innovation of the Year award for its new broadband photon omni-tomography technology for  PET, SPECT, CT and Optical Imaging. For the first time,  PET and SPECT images can be acquired at unprecedented high resolutions, even for PET isotopes that exhibit positron ranges of several mm’s such as 82Rb, 86Y, 76Br and, 124I. Moreover, multiple PET isotopes, or a mix of PET and SPECT tracers, can be imaged simultaneously. Efficient imaging of lower-energy X-ray photons, and attenuation-corrected 3D/4D tomography for optical photon applications, further expand the unique application range of preclinical Broadband Photon Tomography beyond the capabilities of current PET, SPECT, CT, and Optical Imaging systems.

MILabs CEO Prof. Frederik Beekman will speak about these scientific preclinical innovations during the final round of award selections. Be sure to attend this exciting event!

When: Friday, September 14th at 10:30 am, during the first 45-minute coffee break
Where: Exhibit Hall 4AB stage (center left of the exhibit hall).


Applications Unlimited

As a result of its advanced high-resolution nuclear radiotherapy imaging capabilities, the application range of MILabs’ VECTor system keeps expanding steadily. Here are some recent publications from our users:
Cancer radiotheranostics targeting carbonic anhydrase-IX with 111In- and 90Y -labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy. Iikuni et al., Theranostics, Apr 2018. 
For a more comprehensive list, view the MILabs Scientific Library here.


Scan different with VECTor6 PET-SPECT

There is an enhanced way to perform preclinical PET on our VECTor6 omni-tomography system. With the advanced VECTor6  platform from MILabs, you get crystal-clear images at 0.6 mm resolution for 18F, devoid of noise caused by random and scattered coincidences. But there is more: PET without positron-range blurring (e.g. for 124I or 82RB), simultaneous multiple-isotope PET (e.g.18F and 124I), radiotherapy imaging of alpha- and beta-emitting isotopes, and sub-mm simultaneous PET and SPECT. No other preclinical PET comes close to offering the capabilities of the new VECTor6 PET.


Better PET starts with image magnification to improve resolution and selective collimation to only detect true photons with accurately defined origins.

Meet us in 2018 at:

WMIC, September 12 – 15, Seattle, WA, USA
SMIM, September 19, Glasgow, Scotland
EANM, October 13 – 17, Dusseldorf, Germany
PNI, November 12, London, United Kingdom
IEEE NSS-MIC, November 10 – 17, Sydney, Australia